| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8794664 | Ophthalmology Retina | 2018 | 5 Pages |
Abstract
In patients undergoing ranibizumab treatment for DME and who had cataract surgery, an average of 2 lines of vision were gained from the last visit before surgery to 1 month after surgery.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Andrew A. MD, MBA, Howard PhD, Linda A. PharmD, MBA, Shamika MD,